We demonstrated that a set of five select AAs (SAA) can increase the expression levels and activities of CFTR, ANO1, and SLC26A9 using an in vitro HBEC culture model to study CF with Class I and Class II mutations. The gene discussed is ANO1; the disease is cystic fibrosis.